• Policy & Insight

Opinion: “We’ve been pushing for change for 20 years. We’re not stopping now”

This year marks 20 years of Cancer Research UK. A chance to reflect on the incredible advances we’ve made and a reminder of how much we have left to achieve. This year marks 20 years of Cancer Research UK. A chance to reflect on the incredible advances we’ve made and a reminder of how much we have left to achieve.

24 January 2022

• For Researchers
• Science & Technology

Seven Centres to form new Cancer Research UK network

From 1 April, we’re investing £100 million over five years into seven Cancer Research UK Centres across the UK. From 1 April, we’re investing £100 million over five years into seven Cancer Research UK Centres across the UK.

24 January 2022

• For Researchers

A new year of expanding research horizons

Two of our Research Committee Chairs take stock of the incredible science done over 2021 and tell us what they are excited about in the year to come Two of our Research Committee Chairs take stock of the incredible science done over 2021 and tell us what they are excited about in the year to come

21 January 2022

• Science & Technology
• Health & Medicine

Prising open the trap: Getting to grips with targeted cancer drug resistance

Cancer Research UK-funded scientists are using innovative techniques to understand how resistance to a targeted cancer drug is unfolding. Cancer Research UK-funded scientists are using innovative techniques to understand how resistance to a targeted cancer drug is unfolding.

10 January 2022

• For Researchers

It’s a fair COP: Why our chief clinician went to a climate change summit

Charlie Swanton, our chief clinician, headed to the world’s most important climate change conference to talk about the links between pollution and lung cancer in never smokers... Charlie Swanton, our chief clinician, headed to the world’s most important climate change conference to talk about the links between pollution and lung cancer in never smokers...

13 December 2021

• Science & Technology
• For Supporters

Touching a nerve: How neuroscience could advance our understanding of cancer

The role of the nervous system in cancer progression remains largely unexplored. Now, our researchers at the Francis Crick Institute and Cancer Research UK Edinburgh Centre are leaning into the unknown to find out how cancer uses nerve cells and networks to survive and grow. The role of the nervous system in cancer progression remains largely unexplored. Now, our researchers at the Francis Crick Institute and Cancer Research UK Edinburgh Centre are leaning into the unknown to find out how cancer uses nerve cells and networks to survive and grow.

1 December 2021

• For Researchers

The incredible value of going public

We speak with two science communication masters about the benefits, ethics and sheer fun of communicating your research to the public. We speak with two science communication masters about the benefits, ethics and sheer fun of communicating your research to the public.

22 November 2021

• For Researchers

Professor Eithne Costello: On the road to early detection

Professor Eithne Costello on the challenges of ambitious trials, the evolution of early detection as a field in its own right and why a guiding framework is all important. Professor Eithne Costello on the challenges of ambitious trials, the evolution of early detection as a field in its own right and why a guiding framework is all important.

12 November 2021

• For Researchers

Taking on DNA repair to tackle cancer

Pioneering therapeutics targeting the damage repair mechanism of DNA polymerase theta in a range of cancers have entered human trials - we tell the story from discovery to translation. Pioneering therapeutics targeting the damage repair mechanism of DNA polymerase theta in a range of cancers have entered human trials - we tell the story from discovery to translation.

5 November 2021

• Health & Medicine

“The power of science”: HPV vaccine proven to dramatically reduce cervical cancer

New results find that the HPV vaccine was shown to dramatically reduce cervical cancer rates by 90% in women in their 20s who were offered it at age 12 to 13. New results find that the HPV vaccine was shown to dramatically reduce cervical cancer rates by 90% in women in their 20s who were offered it at age 12 to 13.

3 November 2021